These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20015187)

  • 1. Psoriatic arthritis: a review.
    Amherd-Hoekstra A; Näher H; Lorenz HM; Enk AH
    J Dtsch Dermatol Ges; 2010 May; 8(5):332-9. PubMed ID: 20015187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of psoriatic arthritis.
    Sharma A; Dogra S
    Indian J Dermatol Venereol Leprol; 2010; 76(6):645-51. PubMed ID: 21079307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of psoriatic arthritis.
    Balakrishnan C; Madnani N
    Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S18-24. PubMed ID: 23974691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.
    Bansback NJ; Ara R; Barkham N; Brennan A; Fraser AD; Conway P; Reynolds A; Emery P
    Rheumatology (Oxford); 2006 Aug; 45(8):1029-38. PubMed ID: 16782734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts and new developments in the treatment of psoriatic arthritis.
    Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C
    Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving recognition of psoriatic arthritis.
    Conaghan PG; Coates LC
    Practitioner; 2009 Dec; 253(1724):15-8, 2-3. PubMed ID: 20120827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
    Pomerantz RG; Mody E; Husni ME; Qureshi AA
    J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria, frequency, and duration of clinical remission in psoriatic arthritis patients with peripheral involvement requiring second-line drugs.
    Cantini F; Niccoli L; Nannini C; Cassarà E; Pasquetti P; Olivieri I; Salvarani C
    J Rheumatol Suppl; 2009 Aug; 83():78-80. PubMed ID: 19661551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptoms.
    Taylor SL; Petrie M; O'Rourke KS; Feldman SR
    J Dermatolog Treat; 2009; 20(6):350-3. PubMed ID: 19878036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriatic arthritis.
    Wollina U; Unger L; Heinig B; Kittner T
    Dermatol Ther; 2010; 23(2):123-36. PubMed ID: 20415819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriatic arthritis: a dermatologist's perspective.
    Snyder RA
    Am J Clin Dermatol; 2010; 11 Suppl 1():19-22. PubMed ID: 20586501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistant cases of psoriatic arthritis: how to manage them.
    Atzeni F; Sarzi-Puttini P; Vena GA
    J Rheumatol Suppl; 2009 Aug; 83():73-5. PubMed ID: 19661549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How early should psoriatic arthritis be treated with a TNF-blocker?
    Harty L; Veale DJ
    Curr Opin Rheumatol; 2010 Jul; 22(4):393-6. PubMed ID: 20520552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
    Simone D; Nowik M; Gremese E; Ferraccioli GF
    J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriatic arthritis: current therapy and future directions.
    Huynh D; Kavanaugh A
    Expert Opin Pharmacother; 2013 Sep; 14(13):1755-64. PubMed ID: 23815157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment strategies for early psoriatic arthritis.
    Olivieri I; D'Angelo S; Palazzi C; Padula A
    Expert Opin Pharmacother; 2009 Feb; 10(2):271-82. PubMed ID: 19236198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the diagnosis and management of psoriatic arthritis.
    Weger W
    G Ital Dermatol Venereol; 2011 Feb; 146(1):1-8. PubMed ID: 21317852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arthritis psoriatica].
    de Rie MA; van Kuijk AW; Goedkoop AY; Tak PP
    Ned Tijdschr Geneeskd; 2007 Aug; 151(31):1716-22. PubMed ID: 17784693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenetic and clinical rationale for TNF-blocking therapy in psoriatic arthritis.
    Punzi L; Podswiadek M; Sfriso P; Oliviero F; Fiocco U; Todesco S
    Autoimmun Rev; 2007 Sep; 6(8):524-8. PubMed ID: 17854743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions.
    Helliwell PS; Taylor WJ;
    J Rheumatol; 2008 Mar; 35(3):472-6. PubMed ID: 18203324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.